These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19465042)

  • 1. Differential cytotoxic effects of arsenic compounds in human acute promyelocytic leukemia cells.
    Charoensuk V; Gati WP; Weinfeld M; Le XC
    Toxicol Appl Pharmacol; 2009 Aug; 239(1):64-70. PubMed ID: 19465042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated arsenic metabolites bind to PML protein but do not induce cellular differentiation and PML-RARα protein degradation.
    Wang QQ; Zhou XY; Zhang YF; Bu N; Zhou J; Cao FL; Naranmandura H
    Oncotarget; 2015 Sep; 6(28):25646-59. PubMed ID: 26213848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang Z; Zhou J; Lu X; Gong Z; Le XC
    Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monomethylated arsenic was the Major methylated arsenic in Red blood cells of acute promyelocytic leukemia patients treated with arsenic trioxide.
    Guo S; Wang X; Gao C; Wu Z; Chen H; Lin L; Guo M; Gao Y; Hai X
    Toxicol Lett; 2021 Sep; 347():78-85. PubMed ID: 33865921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
    Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative cytotoxicity of fourteen trivalent and pentavalent arsenic species determined using real-time cell sensing.
    Moe B; Peng H; Lu X; Chen B; Chen LWL; Gabos S; Li XF; Le XC
    J Environ Sci (China); 2016 Nov; 49():113-124. PubMed ID: 28007166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trivalent methylated arsenic metabolites induce apoptosis in human myeloid leukemic HL-60 cells through generation of reactive oxygen species.
    Rehman K; Fu YJ; Zhang YF; Wang QQ; Wu B; Wu Y; Zhou XY; Sun WH; Sun TF; Naranmandura H
    Metallomics; 2014 Aug; 6(8):1502-12. PubMed ID: 24870979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exceptions in patterns of arsenic compounds in urine of acute promyelocytic leukaemia patients treated with As2O3.
    Šlejkovec Z; Podgornik H; Černelč P; Falnoga I
    Biometals; 2016 Feb; 29(1):107-18. PubMed ID: 26671504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of arsenic compounds on growth, cell-cycle distribution and apoptosis of tretinoin-resistant human promyelocytic leukemia cells.
    Sakai C; Arai M; Tanaka S; Onda K; Sugiyama K; Hirano T
    Anticancer Res; 2014 Nov; 34(11):6489-94. PubMed ID: 25368250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elimination of the differential chemoresistance between the murine B-cell lymphoma LY-ar and LY-as cell lines after arsenic (As2O3) exposure via the overexpression of gsto1 (p28).
    Giri U; Terry NH; Kala SV; Lieberman MW; Story MD
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):511-21. PubMed ID: 15761769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidation and methylation status determine the effects of arsenic on the mitotic apparatus.
    Kligerman AD; Doerr CL; Tennant AH
    Mol Cell Biochem; 2005 Nov; 279(1-2):113-21. PubMed ID: 16283520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsemide increases arsenic concentrations by inhibition of multidrug resistance protein 4 in arsenic trioxide treated acute promyelocytic leukemia patients.
    Lv J; Wu M; Pang C; Duan R; Zhang H; Tian S; Yang H; Hai X
    Biomed Pharmacother; 2023 Jul; 163():114858. PubMed ID: 37172335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of arsenic species in cerebrospinal fluid (CSF) of acute promyelocytic leukaemia (APL) patients treated with arsenic trioxide plus mannitol.
    Guo M; Zhao Q; Fan S; Wu Z; Lin L; Chen H; Gao Y; Hai X
    Br J Clin Pharmacol; 2021 Oct; 87(10):4020-4026. PubMed ID: 33638869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arsenic speciation in hair and nails of acute promyelocytic leukemia (APL) patients undergoing arsenic trioxide treatment.
    Chen B; Cao F; Lu X; Shen S; Zhou J; Le XC
    Talanta; 2018 Jul; 184():446-451. PubMed ID: 29674067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monomethylarsonous acid binds to Cys-104α and Cys-112β of hemoglobin in acute promyelocytic leukemia patients treated with arsenic trioxide.
    Gao C; Lin L; Li J; Wu M; Lv J; Tian S; Hai X
    Toxicol Lett; 2023 May; 380():31-39. PubMed ID: 37024065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia.
    Cai X; Shen YL; Zhu Q; Jia PM; Yu Y; Zhou L; Huang Y; Zhang JW; Xiong SM; Chen SJ; Wang ZY; Chen Z; Chen GQ
    Leukemia; 2000 Feb; 14(2):262-70. PubMed ID: 10673743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug resistance protein 1 (ABCC1) confers resistance to arsenic compounds in human myeloid leukemic HL-60 cells.
    Xu S; Zhang YF; Carew MW; Hao WH; Loo JF; Naranmandura H; Le XC
    Arch Toxicol; 2013 Jun; 87(6):1013-23. PubMed ID: 23052202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells.
    Estrov Z; Manna SK; Harris D; Van Q; Estey EH; Kantarjian HM; Talpaz M; Aggarwal BB
    Blood; 1999 Oct; 94(8):2844-53. PubMed ID: 10515888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time course of arsenic species in red blood cells of acute promyelocytic leukemia (APL) patients treated with single agent arsenic trioxide.
    Guo M; Wang B; Liu S; Wang W; Gao C; Hu S; Fan S; Hai X; Zhou J
    Expert Rev Clin Pharmacol; 2019 Apr; 12(4):371-378. PubMed ID: 30795697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.